Hyperhomocysteinemia-induced vascular damage in the minipig: Captopril-hydrochlorothiazide combination prevents elastic alterations

Circulation

Volumn 91, Issue 4, 1995, Pages 1161-1174

  Rolland, Pierre H ^a   Friggi, Alain ^a   Barlatier, André ^a   Piquet, Philippe ^b   Latrille, Valérie ^a   Faye, Marie M ^a   Guillou, Joël ^c   Charpiot, Philippe ^a   Bodard, Heidi ^a   Ghiringhelli, Odette ^a   Calaf, Raymond ^a   Luccioni, Roger ^b   Garçon, Danielle ^a  

^a INSERM   (France)

^b TIMONE HOSPITAL   (France)

^c SANOFI   (France)

Author keywords

angiotensin; diuretics; hemodynamics; minipigs; rheology

Indexed keywords

CAPTOPRIL; CYSTATHIONINE BETA SYNTHASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROCHLOROTHIAZIDE; METHIONINE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD RHEOLOGY; CONTROLLED STUDY; DRUG POTENTIATION; ENZYME INHIBITION; HISTOPATHOLOGY; HOMOCYSTINURIA; NONHUMAN; PRIORITY JOURNAL; RIGIDITY; SWINE; VASCULAR RESISTANCE; VISCOELASTICITY;

EID: 0028907052     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.91.4.1161     Document Type: Article

References (67)

1. Mudd SH, Levy HL. Disorders of transulfuration. In: Standbury JB, Wybgaarden JB, Fredrickson DS, eds. The Metabolic Basis of Inherited Diseases. New York, NY: McGraw-Hill Book Co; 1978;458-503.
2. Boers GHJ, Smals AG, Trijbels FJ. Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. N Engl J Med. 1985;6:725-730.
3. Malinow MR, Kang SS, Taylor LM, Wong PWK, Coull B, Inahara T, Mukerjee D, Sexton G, Upson B. Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease. Circulation. 1989;79:1180-1188.
4. Brattstrom LE, Lindgren A, Israelsson B, Malinow MR, Norrving B, Upson B, Hamfelt A. Hyperhomocysteinemia in stroke: prevalence, cause, and relationships to type of stroke and stroke risk factors. Eur J Clin Invest. 1992;22:214-221.
5. Malinow MR, Nieto JF, Szklo M, Chambless LE, Bond G. Carotid artery intimal-medial wall thickening and plasma homocyst(e)ine in asymptomatic adults: the Atherosclerosis Risk in Communities Study. Circulation. 1993;87:1107-1113.
6. McKully KS. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol. 1969; 56:111-121.
7. McCully KS, Ragsdale BD. Production of atherosclerosis by homocysteinemia. Am J Pathol. 1970;61:1-8.
8. Donahue S, Sturman JA, Gaull GE. Arteriosclerosis due to homocyst(e)inemia. Am J Pathol. 1974;77:167-172.
9. Hladovec J. Experimental homocystinemia, endothelial lesions and thrombosis. Blood Vessels. 1979;16:202-205.
10. Harker LA, Ross R, Slichter SJ, Scott CR. Homocystine-induced arteriosclerosis: the role of endothelial cell injury and platelet response in its genesis. J Clin Invest. 1976;58:731-741.
11. Wall RT, Harlan JM. Homocysteine-induced endothelial cell injury in vitro: a model for the study of vascular injury. Thromb Res. 1980;18:113-121.
12. Reddy GSRR, Wilcken DEL. Experimental homocysteinemia in pigs: comparison with studies in sixteen homocystinuric patients. Metabolism. 1982;31:778-783.
13. Dudman NPB, Wilcken DEL. Homocysteine thiolactone and experimental homocysteinemia. Biochem Med. 1992;27:244-253.
14. 6 deficiency: a model for the study of cystathionine β-synthase deficiency. J Nutr. 1982;112:1264-1272.
15. Rinehart JF, Greenberg LD. Pathogenesis of experimental arteriosclerosis in pyridoxine deficiency with notes on similarities to human arteriosclerosis. Arch Pathol. 1951;51:12-18.
16. Krishnaswamy K, Rao SB. Failure to produce atherosclerosis in Macaca radiata on a high-methionine, high-fat, pyridoxine-deficient diet. Atherosclerosis. 1977;27:253-258.
17. Zezulka AY, Calloway DH. Nitrogen retention in men fed isolated soybean protein supplemented with L-methionine, D-methionine, N-acetyl-L-methionine or inorganic sulfate. J Nutr. 1976; 106:1286-1291.
18. 6: relationship to atherosclerosis. J Nutr. 1983;113:2122-2133.
19. Hagemeister H, Scholz-Ahrens KE, Schulte-Coerne H, Barth CA. Plasma amino acids and cholesterol following consumption of dietary casein or soy protein in minipigs. J Nutr. 1990; 120:1305-1311.
20. Gibson JB, Carson NAJ, Neill DW. Pathological findings in homocystinuria. J Clin Pathol. 1964;17:427-437.
21. Carey MC, Donovan DE, Fitzgerald O, McAuley FD. Homocystinuria: clinical and pathological review of ten cases. Am J Med. 1968;45:7-21.
22. Rolland PH, Jouve R, Pellegrin E, Mercier C, Serradimigni A. Alterations in prostacyclin and prostaglandin E2 production: correlation with changes in human aortic atherosclerosis disease. Arteriosclerosis. 1984;4:70-78.
23. Nakamura H, Ohtsubo K. Ultrastructure appearance of atherosclerosis in human and experimentally-induced animal models. Electr Microsc Rev. 1992;5:129-170.
24. McGill HC Jr. The Geographic Pathology of Atherosclerosis. Baltimore, Md: Williams & Wilkins Co; 1968:1-193.
25. Stary HC, Blankenhorn DH, Chandler AB, Glagov S, Insull W, Richardson M, Rosenfeld ME, Schaffer SA, Schwartz CJ, Wagner WD, Wissler RW. A definition of the intima of human arteries and of its atherosclerosis-prone regions. Arterioscler Thromb. 1992;12:120-134.
26. French JUE, Jennings MA, Florey HW. Morphological studies on atherosclerosis in swine. Ann N Y Acad Sci. 1965;127:780-799.
27. Charpiot P, Rolland PH, Friggi A, Piquet P, Scalbert E, Bodard H, Barlatier A, Latrille V, Tranier P, Mercier C, Luccioni R, Calaf R, Garçon D. ACE inhibition with perindopril and atherogenesis-induced structural and functional changes in minipig arteries. Arterioscler Thromb. 1993;13:1125-1138.
28. Levy BI, Michel JBB, Salzmann JL, Azizi M, Poitevin P, Safar ME, Camillieri JP. Effects of chronic inhibition of converting enzyme on mechanical and structural properties of arteries in rat renovascular hypertension. Circ Res. 1988;63:227-239.
29. Simon AC, Lurent S, Levenson JA, Bouthier JE, Safar ME. Estimation of forearm arterial compliance in normal and hypertensive men from simultaneous pressure and flow measurements in the brachial artery, using a pulsed Doppler device and a first-order arterial model during diastole. Cardiovasc Res. 1983;17:331-338.
30. Rolland PH, Charpiot P, Friggi A, Piquet P, Barlatier A, Scalbert E, Bodard H, Tranier P, Mercier C, Luccioni R, Garçon D. Effects of angiotensin converting enzyme inhibition with perindopril on hemodynamics, arterial structure and wall rheology in the hindquarter of atherosclerotic minipigs. Am J Cardiol. 1993;71:1-7.
31. Rolland PH, Souchet T, Friggi A, Berenger-Bahuet FP, Bodard H, Faye MM, Garçon D, Charpiot P, Barlatier A, Calaf R, Lafont H, Lechene P, Domingo N, Piquet P, Tranier P, Mercier C, Luccioni R. Histopathologic and hemodynamic evidences of enalapril-induced reduction of vascular atherosclerotic disease in Pitman-Moore mini-pigs. In: MacGregor GA, Sever P, eds. Recent Advances in ACE Inhibition. London, UK: Churchill-Livingstone; 1991;2:153-156.
32. Rolland PH, Souchet T, Friggi A, Berenger-Bahuet FP, Bodard H, Faye MM, Garçon D, Charpiot P, Barlatier A, Calaf R, Lafont H, Lechene P, Domingo N, Piquet P, Tranier P, Mercier C, Luccioni R. Angiotensin converting enzyme inhibition-induced changes in patterns of hemodynamics, aorta viscoelasticity, arterial histopathology and endothelial cholesterol fluxes of atherosclerotic Pitman-Moore mini-pigs. J Hypertens. 1991;9:S178-S179.
33. Chillon JM, Capdeville-Atkinson C, Lartaud I, Guillou J, Mertès PM, Atkinson J. Chronic antihypertensive treatment with captopril plus hydrochlorothiazide improves aortic distensibility in the spontaneously hypertensive rat. Br J Pharmacol. 1992;107:710-714.
34. 12 deficiency than in heterozygosity for homocystinuria due to cystathionine β-synthase deficiency. Metabolism. 1988;37:175-178.
35. Oster JR, Epstein M. Fixed-dose combination medications for the treatment of hypertension: a critical review. J Clin Hypertens. 1987;3:278-293.
36. Chung TK, Baker DH. Efficiency of dietary methionine utilization by young pigs. J Nutr. 1992;122:1862-1869.
37. Finkelstein JD. Methionine metabolism in mammals. J Nutr Biochem. 1990;1:228-237.
38. Kinoshita A, Urata H, Bumpus FM, Husain A. Measurement of angiotensin I converting enzyme inhibition in the heart. Circ Res. 1993;73:51-60.
39. McEwan JR, Benjamin N, Larkin S, Fuller RW, Doollery CT, MacIntyre I. Vasodilation by calcitonin gene-related peptide and substance P: a comparison of their effects on resistance and capacitance vessels of human forearms. Circulation. 1988;77:1072-1080.
40. Friggi A, Bodard H, Berenger FP, Esclapez F, Rolland PH. Effects of SIN-1 on peripheral hemodynamics and viscoelastic properties of aorta in anesthetized rabbits. Cardiovasc Drugs Ther. 1989; 3:445-448.
41. Pagani M, Mirsky I, Baig H, Manders WT, Kerkhof P, Vatner SF. Effects of age on pressure-diameter and elastic stiffness-stress relationships in unanesthetized sheep. Circ Res. 1979;44:420-429.
42. Benevenga NJ. Amino acid metabolism in swine: applicability to normal and altered amino acid metabolism in humans. In: Tmumbleson ME, ed. Swine in Biomedical Research. New York, NY: Plenum Press; 1986:1017-1030.
43. Dudman NPB, Wilcken DEL, Stocker R. Circulating lipid hydroperoxide levels in human hyperhomocysteinemia: relevance to development of arteriosclerosis. Arterioscler Thromb. 1993; 13:512-516.
44. Harker LA, Slichter SJ, Scott CR, Ross R. Homocystinemia: vascular injury and arterial thrombosis. N Engl J Med. 1974;291:537-543.
45. Stamler JS, Osborne JA, Jaraki O, Rabbani LE, Mullins M, Singel D, Loscalzo J. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest. 1993;91:308-318.
46. Lentz SR, Sadler JE. Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine. J Clin Invest. 1991;88:1906-1912.
47. Gow BS. The influence of vascular smooth muscle on the viscoelastic properties of blood vessels. In: Bergel DH, ed. Cardiovascular Fluid Dynamics. London, UK: Academic Press; 1972:65-110.
48. Hallock P, Benson IC. Studies on the elastic properties of human isolated aorta. J Clin Invest. 1937;16:595-604.
49. Burton AC. Relation of structure-function in tissues of the wall of blood vessels. Physiol Rev. 1954;34:619-642.
50. Yamabe H, Okumura K, Ishizaka H, Tsuchiya T, Yasue H. Role of endothelium-derived nitric oxide in myocardial reactive hyperemia. Am J Physiol. 1992;263:H8-H14.
51. Larkin SW, Williams TJ. Evidence for sensory nerve involvement in cutaneous reactive hyperemia in humans. Circ Res. 1993; 73:147-154.
52. McEwan J, Larkin S, Davies G, Chierchia S, Brown M, Stevenson J, MacIntyre I, Maseri A. Calcitonin gene-related peptide: a potent dilator of human epicardial coronary arteries. Circulation. 1986;74:1243-1247.
53. Kimura E, Hashimoto K, Furukawa S, Hayakawa H. Changes in bradykinin level in coronary sinus blood after experimental occlusion of a coronary artery. Am Heart J. 1973;85:635-647.
54. Geer JC, McGill HC Jr, Strong JP. The fine structure of human atherosclerotic lesions. Am J Pathol. 1961;38:263-287.
55. Lindner V, Reidy MA. Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against fibroblast growth factor. Proc Natl Acad Sci U S A. 1991;88:3739-3743.
56. Jawien AD, Bowen-Pope DF, Lindner V, Schwartz SM, Clowes AW. Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty. J Clin Invest. 1992;89:507-511.
57. Jackson CL, Raines EW, Ross R, Reidy MA. Role of endogenous platelet-derived growth factor in arterial smooth muscle cell migration after balloon catheter injury. Arterioscler Thromb. 1993;13:1218-1226.
58. McAreavey D, Robertson JIS. Angiotensin converting enzyme inhibitors and moderate hypertension. Drugs. 1990;40:326-345.
59. Costa FV, Borghi C, Boschi S, Ambrosiani E. Differing dosages of captopril and hydrochlorothiazide in the treatment of hypertension: long-term effects on metabolic values and intracellular electrolytes. J Cardiovasc Pharmacol. 1985;7(suppl 1):S70-S76.
60. Contard F, Glukhova M, Marotte F, Narcisse G, Schatz C, Swynghedauw B, Guez D, Samuel JL, Rappaport L. Diuretic effects on cardiac hypertrophy in the stroke prone spontaneously hypertensive rat. Cardiovasc Res. 1993;27:429-434.
61. Kiowski W, Linder L, Kleinbloesem C, Van Brummelen P, Bühler FR. Blood pressure control by the renin-angiotensin system in normotensive subjects. Circulation. 1992;85:1-8.
62. Farhy RD, Carretero OA, Ho KL, Scicli AG. Role of kinins and nitric oxide in the effects of angiotensin converting enzyme inhibitors on neointima formation. Circ Res. 1993;72:1202-1210.
63. Dzau VJ, Safar ME. Large conduit arteries in hypertension: role of the vascular renin-angiotensin system. Circulation. 1988;77:947-954.
64. Powell JS, Clozel JP, Muller RK, Kuhn H, Hefti F, Hosang M, Baumgartner HR. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science 1989;245:186-188.
65. Campa JS, Greenhalgh RM, Powell JT. Elastin degradation in abdominal aorta aneurysm. Atherosclerosis. 1987;65:13-21.
66. Wolf G, Haberstroh U, Neilson EG. Angiotensin-II stimulates the proliferation and biosynthesis of type-I collagen in cultured murine mesangial cells. Am J Pathol. 1992;140:95-107.
67. Sandberg LB, Soskel NT, Leslie JG. Elastin structure, biosynthesis, and relation to disease states. N Engl J Med. 1981;304:566-579.